Introduction
Microsomal epoxide hydrolase (mEH) is a member of an a W b-hydrolase family and catalyzes the hydrolysis of a wide range of arene and aliphatic epoxides by transaddition of water to form glycols. 1, 2) This enzyme has been reported to be localized at the cytosolic side of the endoplasmic reticulum membrane in all examined tissues, with the highest activity in the 
liver.
3) mEH activity has been extensively characterized with exogenous drug and chemical substrates. In these cases, the majority of epoxides are thought to be formed by cytochrome P450-mediated oxidation, such as CYP3A4-catalyzed 10,11-epoxidation of the antiepileptic drug carbamazepine. 4) mEH also plays important roles in the detoxiˆcation of metabolically formed hazardous epoxides derived from chemicals such as styrene 7,8-oxide and benzo[a]pyrene 4,5-oxide.
1,2) Thus, mEH is an important enzyme involved in drug e‹cacy and chemical carcinogenicity.
The rates of mEH-catalyzed hydrolysis of benzo[a]pyrene 4,5-oxide diŠer approximately 40-fold between individual human blood lymphocytes. 5) This diŠerence has been suggested to be attributed to EPHX1 genetic polymorphisms. Hassett et al. reported two polymorphisms (Y113H and H139R) and analyzed their eŠects on enzyme activity using the substrate benzo[a]pyrene 4,5-oxide.
6) Raaka et al. found 7 nucleotide changes in the EPHX1 promoter region, three of which resulted in a 30z reduction of transcriptional activity in a reporter gene assay. 7) As for the Japanese population, Saito et al. reported 33 EPHX1 polymorphisms, including 17 novel ones, using genomic DNA from 48 Japanese individuals. 8) Recently, we have detected 5 non-synonymous single nucleotide (SNPs) polymorphisms, including Y113H and H139R, using DNA from 72 established cell lines from Japanese individuals, and characterized their functional eŠect on catalyzing the hydrolysis of cisstilben oxide. 9) Two of the non-synonymous changes in‰uenced the activities in vitro, but not dramatically. In this study, we sequenced all exons and surrounding introns of EPHX1 from 96 Japanese epileptic patients, and identiˆedˆve novel SNPs.
Materials and Methods
Human DNA samples: DNA was extracted from the blood leukocytes of 96 Japanese epileptic patients. Both of the ethics committees of the National Center for Neurology and Psychiatry and the National Institute of Health Sciences approved this study. Written informed consent was obtained from all patients.
PCR conditions and DNA sequencing: PCR ampliˆcation and DNA sequencing were performed as described previously. 9) All the detected novel SNPs were conˆrmed by repeating the PCR on genomic DNA and sequencing the newly generated PCR products.
Results and Discussion
We detected 5 novel SNPs, which are described below. The nucleotide sequences of the PCR-ampliˆed DNA were completely identical to the EPHX1 reference sequence NTä004525.12, except for these SNPs. 1) SNP, MPJ6äEX1009; GENE NAME, EPHX1 AC-CESSION NUMBER, NTä004525.12; LENGTH, 25 bases; 5?-CCTCACTTCAGTG W ACTGGGCTTTGCC-3?.
2) SNP, MPJ6äEX1013; GENE NAME, EPHX1 ; ACCESSION NUMBER, NTä004525.12; LENGTH, 25 bases; 5?-TCCGCAGCCAGGG W CAGGACGACAGCA-3?.
3) SNP, MPJ6äEX1026; GENE NAME, EPHX1 ; ACCESSION NUMBER, NTä004525.12; LENGTH, 25 bases; 5?-GTTCTCCCTGGAC W TGACCTGCTGACC-3?. 4) SNP, MPJ6äEX1028; GENE NAME, EPHX1 ; ACCESSION NUMBER, NTä004525.12; LENGTH, 25 bases; 5?-AGGCAGGGGGACG W AGCCAGTCTTGGG-3?. 5) SNP, MPJ6äEX1030; GENE NAME, EPHX1 ; ACCESSION NUMBER, NTä004525.12; LENGTH, 25 bases; 5?-TGAAAAGTGGGTG W AAGGTTCAAGTAC-3?.
The electropherograms of the novel SNPs are shown in Fig. 1 . The cDNA positions of these SNPs were 30 (A of the translational start codon is numbered as 1) (MPJ6äEX1009) and 130 (MPJ6äEX1013) in exon 2, 1056 (MPJ6äEX1026) in exon 8, IVS8＋54 (MPJ6äEX-1028) in intron 8, and 1239 (MPJ6äEX1030) in exon 9. MPJ6äEX1028 was found in the homozygous and heterozygous state, with a frequency of 0.016. The other SNPs were heterozygous, with a 0.05 frequency.
Of these SNPs, MPJ6äEX1013 (130GÀC) resulted in an amino acid alteration (E44Q). Codon 44 is distant from the catalytic site (D226, E404, and H431), but is adjacent to amino acid residue 43, when altered (R43T caused by 128GÀC), was previously shown to increase hydrolase activity to cis-stilbene oxide.
9) The other three SNPs in the coding region (MPJ6äEX1009, MPJ6äEX-1026, and MPJ6äEX1030) cause synonymous amino acid changes (V10V, D352D, and V413V, respectively). The biological signiˆcance of these changes is currently unknown.
